A Trial of HRS-3095 in Healthy Volunteers
Recruiting
Early Phase 1
Interventional Study
Chronic Spontaneous Urticaria
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
At a Glance
- Age
- 18 – 55
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 36 (estimated)
- Sponsor
- Atridia Pty Ltd. · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Main inclusion criteria
1. Healthy white participants.
2. Male or female aged between 18 years and 55 years (inclusive)
3. Ability to understand the trial procedures and possible adverse events, volunteer to participate in the trial, and provide written informed consent, be able to comply with all …
Contacts